Metabolic-related outcomes include BMI, dyslipidemia, fasting plasma glucose, HDL cholesterol, HOMA-IR, insulin, overweight/obesity, percent body fat, type II diabetes (T2D), triglycerides, and waist-to-height adjusted BMI. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.